https://stock.noler.com/us/stock/tengjun-biotechnology-corp https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable-and-accrued-liabilities-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable-and-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable-and-other-accrued-liabilities-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accounts-payable-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accrued-income-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accrued-income-taxes-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accrued-payroll-taxes-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accrued-professional-fees-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accumulated-depreciation https://stock.noler.com/us/stock/tengjun-biotechnology-corp/accumulated-depreciation-depletion-and-amortization-reclassifications-from-property-plant-and-equipment https://stock.noler.com/us/stock/tengjun-biotechnology-corp/additional-paid-in-capital https://stock.noler.com/us/stock/tengjun-biotechnology-corp/additional-paid-in-capital-common-stock https://stock.noler.com/us/stock/tengjun-biotechnology-corp/adjustments-noncash-items-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/adjustments-to-reconcile-net-income-loss-to-cash-provided-by-used-in-operating-activities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/advertising-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/aoci https://stock.noler.com/us/stock/tengjun-biotechnology-corp/asset-impairment-charges https://stock.noler.com/us/stock/tengjun-biotechnology-corp/bank-overdrafts https://stock.noler.com/us/stock/tengjun-biotechnology-corp/basic-shares https://stock.noler.com/us/stock/tengjun-biotechnology-corp/buybacks-share-repurchases https://stock.noler.com/us/stock/tengjun-biotechnology-corp/buybacks-shares-repurchased https://stock.noler.com/us/stock/tengjun-biotechnology-corp/buybacks-shares-repurchased-value https://stock.noler.com/us/stock/tengjun-biotechnology-corp/buybacks-treasury-stock-cost https://stock.noler.com/us/stock/tengjun-biotechnology-corp/capital https://stock.noler.com/us/stock/tengjun-biotechnology-corp/capital-expenditures https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-and-cash-equivalents-change https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-and-equivalents https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-and-restricted-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-change https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-equivalents-at-carrying-value https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cash-flow-breakdown https://stock.noler.com/us/stock/tengjun-biotechnology-corp/commitments-and-contingencies https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-capital-shares-reserved-for-future-issuance https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-other-shares-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-share-subscribed-but-unissued-subscriptions-receivable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-value https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-stock-value-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/common-unit-issued https://stock.noler.com/us/stock/tengjun-biotechnology-corp/comprehensive-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/comprehensive-income-net-of-tax-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/comprehensive-income-net-of-tax-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/construction-in-progress-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cost-of-goods-sold-direct-financing-lease https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cost-of-revenue https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cost-of-revenue-2 https://stock.noler.com/us/stock/tengjun-biotechnology-corp/costs-and-expenses https://stock.noler.com/us/stock/tengjun-biotechnology-corp/cover-page-shares-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/current-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/current-foreign-tax-expense-benefit https://stock.noler.com/us/stock/tengjun-biotechnology-corp/current-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/customer-advances-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/debt-decrease-forgiveness https://stock.noler.com/us/stock/tengjun-biotechnology-corp/debt-interest-rate https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-foreign-income-tax-expense-benefit https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-income-tax-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-revenue https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-revenue-additions https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-tax-assets-operating-loss-carryforwards https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-tax-assets-operating-loss-carryforwards-domestic https://stock.noler.com/us/stock/tengjun-biotechnology-corp/deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tengjun-biotechnology-corp/depreciation https://stock.noler.com/us/stock/tengjun-biotechnology-corp/derivative-average-exchange-rate-cap https://stock.noler.com/us/stock/tengjun-biotechnology-corp/development-stage-enterprise-deficit-accumulated-during-development-stage https://stock.noler.com/us/stock/tengjun-biotechnology-corp/diluted-shares https://stock.noler.com/us/stock/tengjun-biotechnology-corp/dividends-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/dividends-common-stock-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/dividends-stock https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-from-officers-or-stockholders-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-from-related-parties https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-from-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-to-officers-or-stockholders https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-to-officers-or-stockholders-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-to-other-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-to-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/due-to-related-parties-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/earnings-per-share-basic-and-diluted https://stock.noler.com/us/stock/tengjun-biotechnology-corp/effect-of-exchange-rate-on-cash-and-restricted-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/effective-tax-rate https://stock.noler.com/us/stock/tengjun-biotechnology-corp/employee-benefits-and-share-based-compensation https://stock.noler.com/us/stock/tengjun-biotechnology-corp/eps https://stock.noler.com/us/stock/tengjun-biotechnology-corp/eps-basic https://stock.noler.com/us/stock/tengjun-biotechnology-corp/equity-method-investment-ownership-percentage https://stock.noler.com/us/stock/tengjun-biotechnology-corp/excess-stock-shares-authorized https://stock.noler.com/us/stock/tengjun-biotechnology-corp/excess-stock-shares-issued https://stock.noler.com/us/stock/tengjun-biotechnology-corp/excess-stock-shares-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/financing-cash-flow https://stock.noler.com/us/stock/tengjun-biotechnology-corp/foreign-currency-exchange-rate-translation https://stock.noler.com/us/stock/tengjun-biotechnology-corp/foreign-currency-transaction-gain-loss-before-tax https://stock.noler.com/us/stock/tengjun-biotechnology-corp/foreign-currency-transaction-gain-loss-unrealized https://stock.noler.com/us/stock/tengjun-biotechnology-corp/general-and-administrative-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/gross-profit https://stock.noler.com/us/stock/tengjun-biotechnology-corp/impairment-of-long-lived-assets-to-be-disposed-of https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-attributable-to-parent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-from https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-from-attributable-to-noncontrolling-entity https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-from-before-interest-expense-interest-income-income-taxes-extraordinary-items-noncontrolling-interests-net https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-from-per-basic-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-loss-from-per-diluted-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-tax https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-tax-at-federal-statutory-rate https://stock.noler.com/us/stock/tengjun-biotechnology-corp/income-taxes-paid https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-accounts-payable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-accounts-payable-and-accrued-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-accounts-payable-and-other-operating-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-accrued-income-taxes-payable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-accrued-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-customer-advances https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-customer-deposits https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-due-from-related-parties https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-due-to-other-related-parties https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-income-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-inventories https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-notes-payable-related-parties https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-notes-payable-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-other-loans https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-other-receivables https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-prepaid-deferred-expense-and-other-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-prepaid-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-prepaid-supplies https://stock.noler.com/us/stock/tengjun-biotechnology-corp/increase-decrease-in-prepaid-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/insurance-recoveries https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-expense-related-party https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-income-expense-net https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-income-other https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-paid https://stock.noler.com/us/stock/tengjun-biotechnology-corp/interest-paid-net https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-adjustments https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-finished-goods https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-raw-materials https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-work-in-process https://stock.noler.com/us/stock/tengjun-biotechnology-corp/inventory-work-in-process-net-of-reserves https://stock.noler.com/us/stock/tengjun-biotechnology-corp/investing-cash-flow https://stock.noler.com/us/stock/tengjun-biotechnology-corp/investment-owned-balance-principal-amount https://stock.noler.com/us/stock/tengjun-biotechnology-corp/investments-and-other-noncurrent-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/lease-and-rental-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/legal-fees https://stock.noler.com/us/stock/tengjun-biotechnology-corp/litigation-settlement-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/loans-and-leases-receivable-related-parties https://stock.noler.com/us/stock/tengjun-biotechnology-corp/loans-assumed https://stock.noler.com/us/stock/tengjun-biotechnology-corp/marketing-and-advertising-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/minority-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-cash-from-financing-activities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-cash-from-operating-activities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-change-in-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-income-loss-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/net-income-loss-attributable-to-parent-diluted https://stock.noler.com/us/stock/tengjun-biotechnology-corp/noninterest-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/noninterest-expense-commission-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/noninterest-expense-transfer-agent-and-custodian-fees https://stock.noler.com/us/stock/tengjun-biotechnology-corp/notes-payable-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/notes-payable-related-parties-classified-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/notes-payable-related-parties-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/oci-foreign-currency-transaction-and-translation-adjustment-net-of-tax https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-cash-flow https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-costs-and-expenses https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-expenses https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-lease-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-lease-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-lease-liability-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-lease-weighted-average-discount-rate-percent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-loss-carryforwards https://stock.noler.com/us/stock/tengjun-biotechnology-corp/operating-loss-carryforwards-valuation-allowance https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-accrued-liabilities-current-and-noncurrent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-additional-capital https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-asset-impairment-charges https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-expenses https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-general-and-administrative-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-general-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-income-tax-expense-benefit https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-loans-payable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-noncash-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-noncash-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-noncash-income-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-nonoperating-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-nonoperating-income-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-operating-activities-cash-flow-statement https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-prepaid-expense-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-receivables https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-receivables-net-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-selling-and-marketing-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/other-selling-general-and-administrative-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/paid-in-capital-other https://stock.noler.com/us/stock/tengjun-biotechnology-corp/paid-in-capital-stock-split https://stock.noler.com/us/stock/tengjun-biotechnology-corp/paid-in-kind-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/payments-for-proceeds-from-other-investing-activities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/payments-to-acquire-longterm-investments https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-shares-facts https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-par-or-stated-value-per-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-shares-authorized https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-shares-issued https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-shares-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-value https://stock.noler.com/us/stock/tengjun-biotechnology-corp/preferred-stock-value-outstanding https://stock.noler.com/us/stock/tengjun-biotechnology-corp/premiums-receivable-gain-loss-on-sale-of-receivables https://stock.noler.com/us/stock/tengjun-biotechnology-corp/prepaid-expense-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/prepaid-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/prepayment-fees-on-advances-net https://stock.noler.com/us/stock/tengjun-biotechnology-corp/pretax-income https://stock.noler.com/us/stock/tengjun-biotechnology-corp/pretax-income-domestic https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-bank-debt https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-commissions-received https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-contributed-capital https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-other-short-term-debt https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-related-party-debt https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-repayment-of-loans-to-purchase-common-stock https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-repayments-of-bank-overdrafts https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-repayments-of-related-party-debt https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-sale-and-maturity-of-marketable-securities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-stock-issued https://stock.noler.com/us/stock/tengjun-biotechnology-corp/proceeds-from-stock-plans https://stock.noler.com/us/stock/tengjun-biotechnology-corp/professional-and-contract-services-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/professional-fees https://stock.noler.com/us/stock/tengjun-biotechnology-corp/profit-loss https://stock.noler.com/us/stock/tengjun-biotechnology-corp/property-plant-and-equipment-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/property-plant-equipment https://stock.noler.com/us/stock/tengjun-biotechnology-corp/public-float https://stock.noler.com/us/stock/tengjun-biotechnology-corp/receivable-from-shareholders-or-affiliates-for-issuance-of-capital-stock https://stock.noler.com/us/stock/tengjun-biotechnology-corp/receivable-with-imputed-interest-net-amount https://stock.noler.com/us/stock/tengjun-biotechnology-corp/related-party-transaction-due-from-to-related-party https://stock.noler.com/us/stock/tengjun-biotechnology-corp/related-party-transaction-other-revenues-from-transactions-with-related-party https://stock.noler.com/us/stock/tengjun-biotechnology-corp/repayments-of-advances-for-construction https://stock.noler.com/us/stock/tengjun-biotechnology-corp/repayments-of-related-party-debt https://stock.noler.com/us/stock/tengjun-biotechnology-corp/research-and-development-expense-software-excluding-acquired-in-process-cost https://stock.noler.com/us/stock/tengjun-biotechnology-corp/restricted-stock-shares-issued-net-of-shares-for-tax-withholdings https://stock.noler.com/us/stock/tengjun-biotechnology-corp/retained-earnings https://stock.noler.com/us/stock/tengjun-biotechnology-corp/retained-earnings-unappropriated https://stock.noler.com/us/stock/tengjun-biotechnology-corp/revenue https://stock.noler.com/us/stock/tengjun-biotechnology-corp/sale-of-stock-consideration-received-per-transaction https://stock.noler.com/us/stock/tengjun-biotechnology-corp/sale-of-stock-number-of-shares-issued-in-transaction https://stock.noler.com/us/stock/tengjun-biotechnology-corp/sale-of-stock-percentage-of-ownership-after-transaction https://stock.noler.com/us/stock/tengjun-biotechnology-corp/sale-of-stock-price-per-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/security-deposit https://stock.noler.com/us/stock/tengjun-biotechnology-corp/selling-and-marketing-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/share-price https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shareholders-equity https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-authorized https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-2 https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-for-stock-awards https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-price-per-share https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-shares-other https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-shares-restricted-stock-award-forfeited https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-issued-shares-restricted-stock-award-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/shares-outstanding-2 https://stock.noler.com/us/stock/tengjun-biotechnology-corp/short-term-borrowings https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-new-shares-sold https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-for-options-exercised https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-change https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-issued-for-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-issued-for-noncash-consideration https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-issued-for-services https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-new-issues https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-shares-purchase-of-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-conversion-of-convertible-securities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-issued-for-cash https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-issued-for-noncash-considerations https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-issued-for-services https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-other https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-purchase-of-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-restricted-stock-award-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-shares-issued-value-share-based-compensation-gross https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stock-issued-value-of-shares-issued-for-stock-awards https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stockholders-equity-change https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stockholders-equity-including-portion-attributable-to-noncontrolling-interest https://stock.noler.com/us/stock/tengjun-biotechnology-corp/stockholders-equity-note-subscriptions-receivable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/supplemental-deferred-purchase-price https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-adjustments-settlements-and-unusual-provisions https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-at-federal-statutory-income-tax-rate https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-change-in-enacted-tax-rate https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-disposition-of-business https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-foreign-income-tax-rate-differential https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-other-adjustments https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-share-based-compensation-excess-tax-benefit-percent https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-tax-credits-foreign https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-rate-reconciliation-tax-credits-research https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-reconciliation-change-in-deferred-tax-assets-valuation-allowance https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-reconciliation-nondeductible-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-reconciliation-state-and-local-income-taxes https://stock.noler.com/us/stock/tengjun-biotechnology-corp/tax-reconciliation-tax-settlements-foreign https://stock.noler.com/us/stock/tengjun-biotechnology-corp/taxes-payable-current https://stock.noler.com/us/stock/tengjun-biotechnology-corp/total-accounts-payable https://stock.noler.com/us/stock/tengjun-biotechnology-corp/total-assets https://stock.noler.com/us/stock/tengjun-biotechnology-corp/total-liabilities https://stock.noler.com/us/stock/tengjun-biotechnology-corp/total-liabilities-and-equity https://stock.noler.com/us/stock/tengjun-biotechnology-corp/travel-and-entertainment-expense https://stock.noler.com/us/stock/tengjun-biotechnology-corp/valuation-allowance-amount https://stock.noler.com/us/stock/tengjun-biotechnology-corp/valuation-allowance-deferred-tax-asset-change-in-amount https://stock.noler.com/us/stock/tengjun-biotechnology-corp/weighted-average-number-of-share-outstanding-basic-and-diluted